TrialClinical and translational medicine2022

A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adults.

Deyan Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.